中國海油(600938.SH):上半年淨利潤797.3億元 同比上升25%
格隆匯8月28日丨中國海油(600938.SH)公佈半年度報吿,2024年上半年,公司實現營業收入2267.7億元,同比增長18%,油氣銷售收入人民幣1,851.1億元,同比上升22.0%;歸母淨利潤人民幣797.3億元,同比上升25.0%;油氣淨產量達362.6百萬桶油當量,同比上升9.3%。根據公司2023年度股東周年大會授權,董事會決定派發2024年中期股息每股0.74港元(含税)。股息將以港元計值和宣派,其中A股股息將以人民幣支付,折算匯率按董事會宣派股息之日前一週的中國人民銀行公佈的港元對人民幣中間價平均值計算;港股股息將以港元支付。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.